Literature DB >> 16086024

Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox.

Erika Hammarlund1, Matthew W Lewis, Shirley V Carter, Ian Amanna, Scott G Hansen, Lisa I Strelow, Scott W Wong, Paul Yoshihara, Jon M Hanifin, Mark K Slifka.   

Abstract

Approximately 50% of the US population received smallpox vaccinations before routine immunization ceased in 1972 for civilians and in 1990 for military personnel. Several studies have shown long-term immunity after smallpox vaccination, but skepticism remains as to whether this will translate into full protection against the onset of orthopoxvirus-induced disease. The US monkeypox outbreak of 2003 provided the opportunity to examine this issue. Using independent and internally validated diagnostic approaches with >or=95% sensitivity and >or=90% specificity for detecting clinical monkeypox infection, we identified three previously unreported cases of monkeypox in preimmune individuals at 13, 29 and 48 years after smallpox vaccination. These individuals were unaware that they had been infected because they were spared any recognizable disease symptoms. Together, this shows that the US monkeypox outbreak was larger than previously realized and, more importantly, shows that cross-protective antiviral immunity against West African monkeypox can potentially be maintained for decades after smallpox vaccination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086024     DOI: 10.1038/nm1273

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  66 in total

1.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques.

Authors:  Flora Engelmann; Alex Barron; Henryk Urbanski; Martha Neuringer; Steven G Kohama; Byung Park; Ilhem Messaoudi
Journal:  Age (Dordr)       Date:  2010-09-03

3.  Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

Authors:  Megan M McCausland; Mohammed Rafii-El-Idrissi Benhnia; Lindsay Crickard; John Laudenslager; Steven W Granger; Tomoyuki Tahara; Ralph Kubo; Lilia Koriazova; Shinichiro Kato; Shane Crotty
Journal:  Antivir Ther       Date:  2010

4.  Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Eric L Simpson; Nichole E Carlson; Mark K Slifka
Journal:  Vaccine       Date:  2007-11-29       Impact factor: 3.641

5.  Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity.

Authors:  M Kathryn Liszewski; Marilyn K Leung; Richard Hauhart; Celia J Fang; Paula Bertram; John P Atkinson
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

6.  Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection.

Authors:  Kevin L Karem; Mary Reynolds; Christine Hughes; Zach Braden; Pragati Nigam; Shane Crotty; John Glidewell; Rafi Ahmed; Rama Amara; Inger K Damon
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

7.  Antibody responses to vaccinia membrane proteins after smallpox vaccination.

Authors:  Steven J Lawrence; Kathleen R Lottenbach; Frances K Newman; R Mark L Buller; Clifford J Bellone; John J Chen; Gary H Cohen; Roselyn J Eisenberg; Robert B Belshe; Samuel L Stanley; Sharon E Frey
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

8.  Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Authors:  Richard N Greenberg; Edgar Turner Overton; David W Haas; Ian Frank; Mitchell Goldman; Alfred von Krempelhuber; Garth Virgin; Nicole Bädeker; Jens Vollmar; Paul Chaplin
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226

9.  Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers.

Authors:  Philippe Bossi; Frédérick Gay; Imène Fouzai; Béhazine Combadière; Geneviève Brousse; Bénédicte Lebrun-Vignes; Jean-Marc Crance; Brigitte Autran; Daniel Garin
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

10.  Endemic human monkeypox, Democratic Republic of Congo, 2001-2004.

Authors:  Anne W Rimoin; Neville Kisalu; Benoit Kebela-Ilunga; Thibaut Mukaba; Linda L Wright; Pierre Formenty; Nathan D Wolfe; Robert Loshima Shongo; Florimond Tshioko; Emile Okitolonda; Jean-Jacques Muyembe; Robert W Ryder; Hermann Meyer
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.